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Anthony Arundel
Several data sources are used to estimate the  
potential impact of innovation in agro-
biotechnology on employment in the European 
agro-food chain. In the late 1990s, approxi-
mately 50,000 jobs were directly due to biotech-
nology. The indirect employment effects are 
likely to be much larger. Four of the five main 
innovation strategies for new plant varieties are 
likely to reduce indirect employment, but the 
fifth, improved quality traits (such as enhanced 
oil content), could increase employment by cre-
ating higher value-added crops, although there 
will be job losses in industrial processing. Field 
test data for Europe and the United States show, 
however, that there has been no detectable shift 
in agro-biotechnology innovation towards quality 
traits. It could be worthwhile for government pol-
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N ESSENTIAL FEATURE of technologies 
that are major economic drivers, such as i n-
formation and communication technology 
(ICT), is that they are pervasive, influencing invest-
ment and employment across many economic sec-
tors (Freeman and Perez, 1988). Although nowhere 
near as pervasive as ICT, biotechnology has possible 
applications in human and animal health, industrial 
processing, and in almost all natural resource-based 
sectors, such as agriculture, forestry, aquaculture, 
and mining (Arundel and Rose, 1999; PEW, 2001). 
The range of applications suggests that biotechnol-
ogy could have a substantial impact on competitive-
ness, economic growth, and employment. These 
potential economic benefits are one of the reasons 
why governments in Europe and elsewhere support 
biotechnology through a range of subsidies (EC, 
2001). 
The pharmaceutical applications of biotechnology 
have attracted the lion’s share of venture capital 
(Sechler, 2001) and public and private R&D, but 
these applications are unlikely to have a substantial 
impact on employment because of the relatively 
small size of the pharmaceutical sector. In 1999, the 
sector had 536,000 employees in the European Un-
ion (EU) (EFPIA, 2001), which is slightly less than 
0.4% of total employment. 
This provides an upper estimate of the possible 
impact of biotechnology on pharmaceutical e m-
ployment if every new drug was a biopharmaceuti-
cal, instead of 16% of new drugs introduced onto the 
world market since 1997 (Ashton, 2001). In contrast, 
according to Burke and Thomas (1997), the greatest 
economic and employment impacts of biotechnology 
are likely to occur in the agro-food production chain, 
which accounts for the majority of the 450 billion 
AAgro-biotechnology, innovation and employment 
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Euro of gross value-added and the nine million jobs 
in the EU that could, potentially, be influenced by 
biotechnology (EC, 2001). 
This article traces the possible effects of innova-
tion in agricultural biotechnology on employment in 
the European agro-food chain. The employment ef-
fects are defined by the fact that agro-biotechnology 
is predominantly a process innovation that faces 
competition from alternative technologies for 
achieving the same end. The analysis assumes that 
European farmers are free to grow approved geneti-
cally modified (GM) crops and that there is minimal 
public opposition to GM foods. Although these as-
sumptions are currently unrealistic, some of the em-
ployment effects of agro-biotechnology will be due 
to GM crops grown for animal feed or industrial 
feed-stocks, both of which might be better accepted 
in the near future by the European public if they  
offer environmental advantages over alternatives. 
The employment estimates draw on several data 
sources, including previous surveys in Europe and 
Canada, interviews with Europe’s largest seed firms, 
a 1999 survey of European seed firms, and an analy-
sis of the European and American field release data 
for GM organisms. 
Employment drivers in agro-food 
New technology can have both direct and indirect 
effects on employment. The direct effects are limited 
to changes in employment within the firm that  
develops and commercialises the technology. In 
agro-biotechnology, the direct employment effects 
occur in firms that develop and sell new GM crop 
varieties. The indirect employment effects occur 
elsewhere in the agro-food production chain, which 
runs from the suppliers of agricultural inputs to the 
final consumers of agricultural products, as shown in 
Figure 1. These indirect employment effects of agro-
biotechnology are likely to be much greater than the 
direct employment effects (Watanabe, 1985; Wörner 
and Reiss, 2001). 
Economic research on the employment effects of 
product and process innovation shows that product 
innovation generally increases employment, but 
process innovation reduces it, unless the new pro-
cess improves quality, increases exports, or consum-
ers respond to a process-induced fall in prices with a 
proportionately greater increase in demand (OECD, 
1996; Smolny, 1998; Wörner and Reiss, 2001). As a 
process technology, it is anticipated that agro-
biotechnology will increase productivity by reducing 
inputs, which in turn will reduce employment. For 
example, GM crop varieties that resist fungal, nema-
tode, and insect pests have the potential to decrease 
demand for chemical pesticides, and therefore em-
ployment in firms that manufacture pesticides. How-
ever, the actual impact of agro-biotechnology 
innovation on employment will be influenced by 
five other factors. 
The first factor is a long-term decline within 
Europe, as in other developed countries, in the share 
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of the workforce that is employed in both agriculture 
and manufacturing, as a result of labour-saving i n-
novation and a relative fall in demand for agricul-
tural and industrial products compared to services. 
Between 1985 and 1997, the share of the workforce 
in agriculture declined in all member states of the 
EU by an average of 35.3%. The fastest rate of de-
cline was 54.1% in Spain, and the slowest rate a still 
substantial 17.4% in the UK (OECD, 1999). Slow 
population growth within the EU also places a major 
constraint on the growth of the European market for 
food crops. 
Second, the main innovation strategy of down-
stream customers in the agro-food chain is to reduce 
costs. Feed and food processors are the largest  
customers of agricultural products. Innovation sur-
veys consistently show that these firms stress  
cost-reduction strategies. For example, the 1993 
Community Innovation Survey of almost 14,000 
innovative European firms evaluated the importance 
of several goals of innovation. Two-thirds of food-
processing firms rated reducing material and energy 
inputs as a ‘very important’ or ‘crucial’ goal (Tait et 
al, 2001). The desire of food processors to reduce 
costs will feed back through the agro-food chain, 
limiting the prices that seed firms can charge for GM 
seeds. 
The third factor, the existence of alternative tech-
nologies combined with low switching costs, acts to 
reinforce the downward pressure on costs in the 
agro-food chain (Arundel, 2001). GM crop varieties 
must compete with other technologies, both on the 
farm and throughout the agro-food chain. These al-
ternatives include non-GM crop varieties, different 
types of GM technology, and non-agricultural  
substitutes. 
For example, phosphorous pollution in waterways 
from pig and chicken manure can be reduced 
through GM feed crops that contain phytase (an en-
zyme that would allow these species to digest phy-
tates in their feed). An alternative is to genetically 
engineer pigs and chickens to secrete phytase in 
their saliva. Another solution that is not dependent 
on agro-biotechnology is to add manufactured phy-
tase to feed. Which option is chosen will depend on 
the relative costs and benefits. 
In some cases, GM crops may never offer the 
most cost-effective solution, because of the cost of 
identity preservation to prevent a GM variety with a 
specific, valuable trait from being mixed with other 
varieties of the same crop. Similar factors could also 
influence the competitiveness of GM ‘functional 
foods’, such as broccoli with high levels of calcium 
or other desirable  properties. Food processors can 
either purchase calcium-enhanced GM broccoli or 
add calcium from other sources to their products. 
Low or negligible switching costs from one input 
to another ensure that a small increase in the price of 
a GM versus a non-GM  input will reduce the d e-
mand, and hence the price, for the GM input. A food 
processor who purchases GM soybeans today will 
incur few, if any, additional production costs by 
switching to a different protein source tomorrow in 
response to a cost advantage (Kane, 2001). Simi-
larly, feed manufacturers need to include lysine in 
poultry feed. If the price of GM corn containing l y-
sine is too high, they can add lysine from industrial 
fermentation (Coaldrake, 1999). 
Fourth, current levels of employment in the Euro-
pean agro-food chain are not sustainable without 
subsidies, as shown by a 10.7% decline in the gross 
value-added of European agricultural output (at 
market prices) between 1990 and 1997. One cause of 
the decline was an increase in the cost of inputs such 
as f ertilizers, pesticides, equipment maintenance, 
and animal feed. The increase in input costs was 
largely met by a 2.3-fold increase in agricultural 
subsidies. A fall in subsidies as a result of reform of 
the European Common Agricultural Policy would 
alter both employment and the types of crops that 
are grown in Europe (OECD, 2000). 
Fifth, the large number of mergers in both the 
seed and agro-chemical sectors in the last decade 
will also reduce employment. As an example, the 
1999 merger of Rhone-Poulenc and AgrEvo to form 
Aventis reduced employment by 3000–4000 jobs, 
with the closure of an R&D centre in the UK and a 
European agro-chemical manufacturing plant. A 
new round of job losses is possible after the pur-
chase of Aventis by Bayer. 
Direct employment impacts 
There is no accurate information on the number of 
direct jobs in agricultural biotechnology in Europe. 
The best option is to estimate direct biotechnology 
employment in the agro-food chain by combining 
different survey estimates. Data from Ernst and 
Young (1997) suggest that there were 5,625 jobs in 
Europe in small agro-biotechnology firms in 1996 
(more recent Ernst and Young surveys did not pro-
vide separate estimates for agro-biotechnology). 
Two surveys by Statistics Canada in 1996 and 1997 
estimate that approximately 1% of food processing 
employees were involved with biotechnology in 
some way (Arundel and Rose, 1998). The same rate 
applied to the 3.3 million food processing jobs in 
Europe predicts 33,000 biotechnology jobs. 
A 1999 survey of European seed and agro-
chemical firms determined the percentage of R&D 
expenditure on genetic engineering and the applica-
tion of these technologies to enhance conventional 
plant breeding (Arundel, 2001). These rates, applied 
to the total number of employees in seed and  
agro-chemical firms, estimate an additional 8,500 
biotechnology jobs. After rounding up to account for 
employment growth (which may not be realistic 
given recent mergers), the final estimate is approxi-
mately 50,000 direct biotechnology jobs in the 
European agro-food chain in the late 1990s. This is a 
very small percentage of total employment. Agro-biotechnology, innovation and employment 
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Indirect employment effects 
Direct biotechnology employment in the agro-food 
chain in Europe is likely to be severely depressed by 
the current regulatory situation,  which prevents 
commercial farming of GM varieties. Furthermore, 
agro-biotechnology is in its infancy, with only a few 
major GM varieties available, such as Bt cotton and 
corn, and herbicide-tolerant corn, soybeans, and 
rapeseed. All these varieties have  had only very 
small or no effects on farmer incomes in the United 
States (Nelson, 2001), which limits their employ-
ment impact, and almost no effect on downstream 
processing. Because of these constraints, there is no 
point in estimating current indirect employment ef-
fects from agro-biotechnology. 
Instead, I provide a qualitative assessment of the 
possible employment effects of different innovation 
strategies in the seed sector. The estimates assume 
no increase in exports and no change in current agri-
cultural  subsidy levels. European demand for agri-
cultural products is assumed to be price inelastic. 
For example, a large decline in the price of wheat 
would only result in a small increase in demand, 
since most markets for wheat are already saturated. 
The exception is for some quality characteristics. 
There are five possible options for innovation in 
plant breeding (DG Agriculture, 2000a). Each will 
have a different effect on indirect employment. Ta-
ble 1 outlines each option and gives a qualitative 
assessment of t he expected employment effects 
through the agro-food chain (with the exception of 
retailers, for whom no employment effects are  
expected). 
The first option of an increase in yield per hectare 
should result in farmers producing more at a given 
price, leading to a fall in crop prices (in the absence 
of an increase in European demand, exports, or sub-
sidies). Without an increase in subsidies, this should 
result in a decline in farm-level employment. 
The second option of an increase in yield per unit 
of inputs could have no effect on farm-level e m-
ployment if yield per hectare is left unchanged, but it 
should decrease employment among input suppliers. 
An example is protective seed dressings or coatings 
that reduce the need for fungicides and other pesti-
cides. This innovation should reduce costs for farm-
ers (thereby increasing farmer incomes), but 
decrease employment among competing pesticide 
firms. 
Risk-reducing innovations could have no effect on 
total yields, but reduce the risk experienced by each 
individual farmer. An example is Bt cotton, which 
should reduce the risk of crop loss from insect pests 
that are susceptible to Bt. The estimated gain to 
farmers from Bt maize compared to conventional 
maize is an increase of US$44.5 per acre with high 
infestation levels and a loss of US$4.5 under low 
infestation levels (OECD, 2000, page 102). 
The trade-off for the farmer is higher initial seed 
costs that are recovered when insect infestation is 
heavy but not when insect infestation is low. Over 
the medium-term, this could have no effect on aver-
age prices and costs. However, the extra cost of risk-
reducing varieties must be paid for in some manner, 
either through an overall increase in yields (resulting 
in declines in farm-level employment) or through 
Table 1. Employment effects of innovation in the seed sector 
Option  Employment effects in the agro-food chain 











1. Increased yield per hectare  --  Œ  --  --  --  ￿ 
2. Increased yield per unit inputs  Œ  --  --  --  --  ￿ 
3. Reduced risk to farmer  Ø  --/￿  --  --  --  -- 
4. Input switching (no yield effect)  æ/￿  --  --  --  --  -- 
5. Enhanced quality characteristics  Ø/Œ  æ  Ø  --/￿  --/￿  æ/Ø 
Key:   Ø = relatively strong positive increase 
æ = weak increase 
Œ = strong decline 
￿ = weak decline 
--/￿ = no effect to weak decline 
-- = no effect 
æ/￿ = substitution effects 
There are five possible options for 
innovation in plant breeding, each 
with its own effect on indirect 
employment: increased yield per 
hectare; increased yield per unit 
inputs; reduced risk to farmer; input 
switching; and enhanced quality 
characteristics Agro-biotechnology, innovation and employment 
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higher seed prices and lower farm incomes. Either 
way, this could translate into lower farm-level  
employment. 
Input switching innovations could have no effect 
on farm-level employment, unless they also increase 
yields, but they should shift employment among the 
input suppliers. For example, the use of imazetaphyr 
declined from 44% of US soybean acres in 1995 to 
17% in 1998, while Roundup use increased from 
10% of acres in 1990 to 45% in 1998 (DG Agricul-
ture, 2000a). These changes in herbicide use patterns 
should have shifted employment from competing 
herbicide manufacturers to Monsanto, the producer 
of Roundup Ready GM soybean varieties and the 
herbicide Roundup. 
The employment effects of each of the first four 
innovation options are largely confined to input sup-
pliers and to the farm level. The predicted employ-
ment effects are either negative or neutral. In 
contrast, quality enhancement is likely to have far 
more complex effects on employment, with shifts in 
employment from one part of the agro-food chain to 
another. Furthermore, quality enhancement is the 
only type of agro-biotechnology innovation that 
could increase total employment in the agro-food 
chain. This would occur by increasing the value-
added component of agricultural products. Quality 
traits with industrial applications, such as the use of 
plant oils for lubricants or improved biomass crops 
for energy production, will also increase agro-food 
employment, although these increases could be 
matched by a decline in employment in industry. 
Quality traits require identity preservation, which 
will increase employment in transport and distribu-
tion. Quality traits will also require an increase in 
crop prices in order to cover the cost of identity 
preservation, which is estimated, based on US  
experience, to cost between 6%  and 17% of the 
farm-gate price, depending on the crop (DG Agricul-
ture, 2000a). Farm-level employment could also i n-
crease slightly if the price paid for improved crops 
increases and if farmers can capture part of the price 
increase. 
One aspect of quality traits could have a net posi-
tive effect on European employment. This is when 
domestic European production replaces imports. Ex-
amples include high lauric acid rapeseed to replace 
imported coconut and palm oil in lubricants and de-
tergents (OECD, 2000) or bioethanol production 
from GM grasses to replace imported petroleum. 
Another example, although a step removed from 
traditional agriculture, is GM bacteria to produce 
natural vanilla and other aromatic botanicals that are 
currently imported (Acharya, 1995). 
Potential markets for GM crops 
The size of possible changes in employment patterns 
as a result of new GM seed varieties depends on the 
market value of GM crops. Interviews with the  
managers of seed firms in Europe (see the other arti-
cles in this issue), plus an analysis of the European 
field test data for GM crops, show that these firms 
are concentrating their GM plant breeding pro-
grammes on major crops such as maize, sugar beets, 
oilseeds and potatoes where large market sizes i n-
crease the potential profits and provide an opportu-
nity to recoup high R&D costs. 
Therefore, a limiting factor on the potential em-
ployment effects of GM seeds is the share of these 
crops out of total crop values in Europe. As shown 
in Table 2, the main GM target crops for Europe 
accounted for only 16.3% of the total crop value in 
1997 (the most recent year available). 
The effect of GM crops on employment in the 
agro-food chain is likely to be comparatively small 
until GM techniques can be applied to other cereals 
(mostly wheat) that account for another 16.3% of 
crop values, and to vegetables, fruits, and vines. 
Monsanto is close to marketing GM wheat that is 
resistant to proprietary herbicides, after over a hun-
dred field trials of this trait in the United States. The 
remaining crops account for over half the total value, 
but many of them have very small markets. 
The employment effect of advanced biotechnol-
ogy will therefore depend on the ability of seed 
firms to apply genetic engineering to small-market 
crops. To date, small-market food crops (excluding 
tomatoes) account for only 6.5% of all GM plant 
field trials in the United States and 7.3% of field 
trials in Europe since the late 1980s. A future i n-
crease in GM research on small-market crops will 
depend on the cost of using GM techniques. As with 
many technologies, these costs should fall over time. 
Is there a shift to quality traits? 
Other than an extension of agro-biotechnology from 
large to small-market crops, the main employment 
Table 2. Value of agricultural crops in the European Union 
  1997 crop values 
  million Ecu  % 
Main GM target crops  17,110  16.3 
 Maize  4,128  3.9 
 Potatoes  4,227  4.0 
 Sugar beets  5,657  5.4 
 Oilseeds  3,098  3.0 
Other cereals (excluding 
maize) 
17,143   16.3 
Vegetables, fruits, and vine 
crops 
55,110  52.5 
Other crops  15,567  14.8 
Total   104,930  100.0 
Sources: OECD (1999); DG Agriculture (2000b) Agro-biotechnology, innovation and employment 
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effect of agro-biotechnology will be a result of qual-
ity traits. These are of great interest as they are the 
only innovation type that could increase employment. 
In the late 1990s, both Monsanto’s Chief Execu-
tive Officer, Robert Shapiro, and Cargill Agricul-
tural Division President, Fritz Corrigan, predicted 
that a quarter of all grain production would be de-
voted to quality or output traits within a decade 
(Morrison and Giovannetti, 1999). Interviews with 
the European managers of seed firms also found that 
several of them are moving to an innovation strategy 
based on quality or output traits such as functional 
foods or neutraceuticals (physiologically beneficial 
products isolated from foods) (Tait, 2001; Chata-
way, 2001). 
Yet, GM crops with quality traits constitute only a 
miniscule percentage of all GM plantings so far. 
Only 0.1% of 41.5 million hectares of GM crops in 
Canada and the United States in 1999 were for qual-
ity traits, primarily high oleic oilseed (DG Agricul-
ture, 2000b). A major shift in firm strategies to 
quality traits would require a significant number of 
new GM crop varieties to come onto the market over 
the next five to ten years. 
Depending on the species and the desired traits, 
eight to twelve years are needed to develop most 
new crop varieties, which means that the timing of 
employment effects from quality traits depends on 
when seed firms began to research these traits. An 
essential step in the development process is to field 
test the variety to ensure the consistent expression of 
the desired traits. Field trials can begin two to three 
years into an R&D project to develop a new seed 
variety and can run almost until the variety is ready 
for commercialisation. Therefore there is a lag be-
tween field trials and market-readiness of one to ten 
years, although the average is probably around five 
or six years from the first field trials. 
In the 1970s and 1980s, concerns about the safety 
of GM varieties among scientists and the general 
public led governments in both the United States and 
Europe to establish field trial registration systems. 
These provide valuable data on the direction of re-
search investment in agricultural biotechnology. 
Field trial data is similar to patent data in providing 
a record of the types of research projects conducted 
by firms. 
This data has one advantage over patents, in that 
firms are unlikely to conduct field trials unless they 
are relatively confident that the variety can be com-
mercialised. Patents are a poorer indicator of innova-
tions because not all innovations are patented (while 
all GM crops to be grown outdoors must be f ield 
tested). 
The main disadvantage of the field trial data is 
similar to that of patents. Although both provide a 
measure of investment in particular lines of research, 
there is no direct correlation between the number of 
field trials (or patents) and the number of commer-
cialised GM plant varieties (or patented innova-
tions). As an example, several hundred field trials 
were conducted in the United States to test tomato 
varieties that ripened without becoming soft. In con-
trast, only 15 field trials were required to develop a 
viral -resistant variety of papaya. 
At the time of writing, the most recent database 
for field trials in the EU includes all field trials up 
until April 2001 (JRC, 2001), while the US database 
includes all field trial applications and notifications 
up until January 2002 (maintained by APHIS of the 
USDA (US Department of Agriculture)). Both data-
bases include the name of the applicant, the purpose 
of the field test, the application year, and the species. 
In addition, APHIS assigns each field test to one or 
more of ten categories based on the trait under inves-
tigation: herbicide tolerance; agronomic characteris-
tics; marker genes; product quality; an ‘other’ 
category; and five types of pest resistance — bacte-
ria, fungi, insect, nematode, and viruses. For exam-
ple, a field test for both insect and viral resistance is 
included in both the insect and viral resistance cat-
egories. Approximately 7% of the US trials for pest 
resistance are for more than one type of resistance. 
For analysis, I assigned the purpose of each EU 
and US field trial to one of five broadly comparable 
trait categories: herbicide tolerance; pest resistance; 
other agronomic characteristics such as yield and 
stress resistance; product quality; and a technical 
category that includes  male sterility, research on 
gene markers and other types of trials. To improve 
comparability with the US data, EU field trials in 
more than one category are counted more than once, 
as are EU field trials for more than one type of pest 
resistance. 
The main problem for analysis is to identify all 
trials for product quality traits, which include both 
industrial applications and food processing charac-
teristics. These trials are assigned in the US APHIS 
database to either the ‘other’ or ‘product quality’ 
categories, but APHIS also includes additional i n-
formation on the enzyme target and on the purpose 
of the trial. The EU database contains a much 
shorter description of the purpose of the trial, a l-
though the enzyme targets are often mentioned. I 
used this information to create a more detailed clas-
sification of industrial and food processing uses. 
However, about 2% of the trials could not be clas-
sified with a high degree of confidence because the 
In the 70s and 80s, concerns about the 
safety of GM varieties led US and 
European governments to establish 
field trial registration systems, which 
provide valuable data on the direction 
of research investment in agricultural 
biotechnology Agro-biotechnology, innovation and employment 
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enzyme target could either serve multiple functions 
or its purpose was unknown. If plausible, these trials 
were assigned to one of the main trait categories, but 
otherwise I assigned them either to the technical 
category or to an ‘other’ group within the product 
quality category. The latter also includes American 
trials that were classified by APHIS under product 
quality, but which lacked additional information  
on the purpose of the trial because of business  
confidentiality. 
I used the information on the applicant in both the 
EU and US databases to determine if the applicant 
was a private firm or from the public sector, such as 
a university or publicly-funded research institution. 
The US APHIS data only list one applicant, but the 
EU data list multiple applicants where relevant. A 
small proportion (1.7%) of the EU field tests include 
an applicant from both the public and private sec-
tors. These field tests are assigned to the public  
sector. 
The results given here are limited to field trial  
applications for higher plant species. Note that all 
results are given for  trial –trait combinations. For 
example, a trial that includes a trait for herbicide 
tolerance and one for pest resistance is counted in 
each of these two categories. After excluding non-
plant species, there are 2,040 European and 9,122 
American trial–trait combinations. 
Results for product quality field trials 
Table 3 gives the number of EU and US field trial –
trait combinations within each of the five main trait 
categories, plus the percentage of trials conducted by 
the public sector. In absolute terms, the USA is more 
active than Europe in product quality trials, with 
1,750 field trials compared to 259 in Europe. In ad-
dition, a higher percentage of all US trials are for 
product quality (19.2%) compared to Europe 
(12.7%). In contrast, the European public sector ac-
counts for almost double the proportion of product 
quality trials (29.0% versus 19.2%). In both regions, 
two traits, herbicide tolerance and pest r esistance, 
account for the majority of trials — 69.2% of the 
total in the USA and 71.4% of the total in Europe. 
Table 4 provides a detailed breakdown of the  
purpose of product quality trials in the USA and the 
EU. Most are for food quality characteristics, such 
as oil content, the types of starches, sugars and pro-
tein in the crop, and the ripening characteristics of 
fruit. Many of these traits should improve the effi-
ciency of food processing, which would decrease 
processing employment while possibly increasing 
employment further down the agro-food chain. 
The industrial and environmental traits include 
low phytase animal feed, fibre inputs, and the use of 
plants as industrial feedstocks for lubricants, poly-
mers, pharmaceuticals, and enzymes. Many of these 
traits could shift some employment from industry to 
agriculture. Although the net employment effect 
could still be negative as a result of more efficient 
production, the same characteristic offers substantial 
environmental benefits through cleaner production 
processes. 
A main question of interest is whether the share of 
product quality traits has been increasing over time, 
perhaps because of a shift in the innovation strat-
egies of seed firms. Relevant results are given in 
Figure 2 for industrial and food processing traits in 
the USA and for all European product quality traits 
combined (there are too few trials for industrial traits 
in Europe to provide separate results, while the 
‘other’ group for the USA is included under food 
Table 3. Distribution of EU and US field trials by trait 
  USA  EU 
  Number  %  Public sector 
share (%) 
Number  %  Public sector 
share (%) 
Herbicide tolerance  2,509  27.5  4.9   980  48.0  9.5 
Pest resistance  3,800  41.7  16.3  477  23.4  18.7 
Other agronomic  394  4.3  25.3  86  4.2  61.6 
Technical  669  7.3  47.3  238  11.7  14.7 
Product quality  1,750  19.2  15.6  259  12.7  29.0 
Total  9,122  100.0  15.0  2,040  100.0  16.9 
 
Table 4. Breakdown of product quality trials 
USA  EU   
Number  %  Number  % 
Industrial/ 
environmental 
201  11.5  61  23.6 
Food quality          
 Oils  214  12.2  16  6.2 
 Starches and 
 sugars 
394  22.5  123  47.5 
 Proteins  496  28.4  12  4.6 
 Fruit ripening  251  14.4  20  7.7 
Other  194  11.1  27  10.4 
Total  1750  100.0  259  100.0 
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processing). The results for 1992 include all trials 
before this date. 
There has been little change over time in the share 
of product quality traits in Europe or industrial traits 
in the USA. The share of trials for food processing 
traits reached a peak of 28% of all US trials in 
1994/95 before falling to 16.4% in 1996/97 and to 
13.3% in 2000/01. Part of the 1994/95 peak was a 
result of trials for ripening in the tomato. Excluding 
this one trait reduces the 1994/95 peak to 23%. 
However, almost all types of food processing trials 
reached a peak between 1994 and 1996 and declined 
afterwards. 
This suggests that seed firms in the USA lost in-
terest in developing GM crops with improved qual-
ity characteristics, compared to other types of traits. 
The main shift was towards technical and agronomic 
traits, for which the share of all GM trials increased 
steadily after 1994 (results not shown). The absolute 
number of trials for food processing traits in the 
USA has fluctuated since the 192 trials in 1994, but 
there is no detectable trend. Conversely, the number 
of trials for industrial traits  increased from 10 in 
1994 to 42 in 2001. 
The share of trials for product quality traits would 
have declined even further except for an increase in 
trials by the public sector. In the USA, the public-
sector share of product quality traits (industrial and 
food processing combined) increased from a low of 
5% of these trials in 1994 to approximately 25% 
between 1999 and 2001. In Europe, the public-sector 
share of product quality trials also increased, a l-
though not as dramatically, from 18% of these trials 
up to 1994 to 43% in 1998 and 39% in 1999. 
It is possible that most of the research by private 
firms on product quality traits has not yet reached 
the field trial stage, with most testing still occurring 
in the laboratory or greenhouse, where a field trial 
application or notification is not required. If true, a 
substantial shift to higher value-added quality traits 
is probably over five years away, given the time re-
quired to field test a GM trait. This also means that 
any possible employment impacts from GM traits 
for product quality are equally distant in time. 
Conclusions 
Policy documents in Europe and in other countries 
such as Australia and Canada have frequently 
stressed the potential economic benefits of biotech-
nology, including increased employment, although 
in the late 1990s the discussion of employment 
changed from an emphasis on new jobs to one on 
high-skilled jobs. The various types of evidence as-
sembled in this article show that most of the e m-
ployment effects of biotechnology are likely to be a 
result of indirect employment effects in the agro-
food chain, plus those in industrial firms that adopt 
agricultural inputs. 
Wörner and Reiss (2001), in a study of the  
German biotechnology industry, also estimate that 
the indirect employment effects of biotechnology are 
likely to be much larger than the direct effects. Fur-
thermore, most types of agro-biotechnology innova-
tion will reduce employment. This will have major 
economic benefits by increasing productivity, com-
petitiveness, and living standards, but an increase in 
employment is not one of them. 
Although agro-biotechnology is unlikely to i n-
crease the number of jobs, it could increase the 
number of higher-skilled jobs that are traditionally 
better paid than lower-skilled jobs in manufacturing 
and agriculture. In a 1997 Statistics Canada survey 
of agro-food firms, 43.2% of these firms (after  
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of biotechnology increased skill requirements, com-
pared to only 1% that reported a decrease (Arundel 
and Rose, 1999). This is encouraging, although the 
increased skill demands could be relatively minor 
and might not translate into greater productivity and 
higher wages. 
Any increase in demand for very high-skilled jobs 
in the agro-food chain is likely to be relatively small. 
For example, the results of the 1999 survey of Euro-
pean seed firms suggest that employment in seed 
research and development would increase by about 
7.4% between 1999 and 2002, which is equivalent to 
about 400 new jobs (Arundel, 2001). Many of these 
expected gains in high-skilled jobs could be lost 
through mergers. 
Of the five innovation options available to seed 
firms, quality traits have the greatest potential to 
increase employment in the agro-food chain. The 
interviews with seed firm managers and published 
statements from seed firm chief executive officers 
suggest that quality traits should play a growing role 
in the innovation strategies of these firms. This 
could have a positive impact on employment in the 
agro–food chain, or at least delay the rate of job 
losses. 
Surprisingly, there is little evidence from the field 
test data to support a marked shift towards quality 
traits. There are several possible explanations. The 
first is technical. Many of these traits could be d e-
veloped using non-GM breeding methods, or it 
could be technically more difficult to develop qual-
ity traits via GM methods than originally thought. 
Second, research on quality traits could still be in the 
laboratory or greenhouse stage and therefore unde-
tectable using the field trial data for Europe and the 
USA. 
Although conjectural, there is also a third possible 
reason. The economic obstacles against quality traits 
could be reducing the private enthusiasm among 
seed firms for these traits, compared to their public 
statements and advertisements (such as for golden 
rice) in support of quality traits. The obstacles i n-
clude the cost of identity preservation, competitive 
alternatives, and low switching costs for farmers and 
for food and industrial processors. This could be one 
reason why the share of field trials for product qual-
ity traits declined in the USA after the mid-1990s. 
Any possible barriers to the development of qual-
ity traits should be of concern to governments, not 
so much because quality traits offer employment 
gains in some sectors, but because of secondary  
environmental benefits. Some quality traits could be 
developed specifically to solve environmental prob-
lems, such as phosphate pollution of waterways. 
Other quality traits that improve food, feed, and i n-
dustrial processing will also provide environmental 
benefits by reducing the amount of inputs or pro-
cessing that is required to achieve a given amount of 
output (OECD, 2001). 
The public sector in both Europe and the USA  
already focuses on product quality traits with  
potential b enefits for employment and the environ-
ment. It may be worthwhile for governments to build 
on this strength by increasing public-sector funding 
for research on applications with environmental or 
other benefits in the public interest. An additional 
benefit is that research on these types of traits might 
help overcome what Gaskell and colleagues (2000) 
describe as the “Achilles heel” of agricultural bio-
technology, which is a lack of useful applications 
that can attract greater public support. 
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